Upload
others
View
3
Download
0
Embed Size (px)
Citation preview
THE EMERGING EULAR NETWORKEDITION MAY-JUNE 2016
EULAR 2016 LONDON
Oral presentations and posters
“The young rheumatologist” sessions
Activities and get together
Mentor/Mentee meetings
The EULAR-EMEUNET Ambassador
Programme
3rd Country Liaison Meeting
EDUCATIONAL EVENTS
EULAR DO NOT MISS
Hilfslinien anzeigen über Menu:
Ursprungsform
im Menü über:
Start | Absatz | Listenebene
DIRECTORY
MAY-JUNE16
EDITORIAL
PAGE 2
Dear young rheumatologistsand researchers inrheumatology,
We are happy to present you a new issue
of EMEUNEWS about the Do-Not-Miss
Topics of this year´s EULAR annual
meeting.
The EULAR congress is the largest
scientific event in Rheumatology. As it is
now approaching, we provide a selection
of oral presentations and posters that we
consider to be noteworthy. Albeit this is a
limited way of looking at the numerous
scientific releases at EULAR 2016, it
might provide an overview of hot topics in
each field of Rheumatology.
This current Newsletter also contains
details about the “Young Rheumatologist”
sessions and other events organized
during the Congress.
Do not forget to visit our EMEUNET
booth to get additional info and meet up
with other young rheumatologists.
EMEUNET is now active in social media
hubs such as Facebook and Twitter,
while maintaining the traditional website
and the important physical (and
personal) presence at major
Rheumatology scientific events.
If this is your first contact with
EMEUNET, we invite you to explore
more and join us. If you are already part
of our community, we kindly remind you
that sharing is caring. Spread the word
about our activities and work, and help us
reach more young rheumatologists and
researchers.
We hope you enjoy reading this
Newsletter. We always welcome
feedback, comments, suggestions and
contributions.
We wish you a prolific and successful
EULAR 2016
See you in London!
Russka Shumnalieva, Richard Conway,
Francesco Carubbi and Alessia Alunno
on behalf of the Newsletter Subgroup
EULAR 2016: ORAL PRESENTATIONS & POSTERS 4
Basic Research I
Basic Research II
RA I
RA II
RA III
Psoriatic Arthritis
Axial Spondyloarthritis
SLE and APS
Other connective tissue diseases
Imaging
Crystal Arthropathies
Osteoarthritis & Osteoporosis
Pediatric Rheumatology
THE YOUNG RHEUMATOLOGIST SESSIONS 16
EMEUNET EVENTS AT EULAR 2016 20
MENTOR MENTEE MEETINGS 21
EULAR EMEUNET AMBASSADOR PROGRAMME 22
3RD COUNTRY LIAISONS MEETING 23
EDUCATIONAL EVENTS 24
This year due to EULAR embargo rules, only
titles and authors of abstracts have been
published ahead of the Congress. Therefore,
please note that the following selection has
been performed based ONLY on abstract titles.
We appreciate your understanding.
Hilfslinien anzeigen über Menu:
Folie in Ursprungsform
Wechsel der Textebene/Formatierungen
Start
PAGE 3
Anna Olewicz-Gawlik, MD PhD is a specialist in clinical immunology and a postdoctoral research fellow at the Department of
Rheumatology and Clinical Immunology at Poznan University of Medical Sciences. Her professional interests focus on
systemic sclerosis, Sjögren’s syndrome and immunology.
BASIC RESEARCH I
Genetics, cartilage/synovium, osteoimmunology, animal models
Anna Olewicz-Gawlik
ORAL PRESENTATIONS & POSTERS EULAR 2016 LONDON
MAY-JUNE16
Type, n° Date, time Session Room Author Title
OP0068
Thursday
09.06.2016
10:20
Cartilage, bone,
synovium
Capital Suite
06
van den Bosch M.
(Netherlands,
United States)
WISP1 INDUCES PATHOLOGY
IN EXPERIMENTAL
OSTEOARTHRITIS AND
PREDICTS DISEASE
PROGRESSION IN EARLY
OSTEOARTHRITIS PATIENTS.
OP0069
Thursday
09.06.2016
10:30
Cartilage, bone,
synovium
Capital Suite
06
Hood J.
(United States)
DISCOVERY OF A SMALL
MOLECULE INHIBITOR OF THE
WNT PATHWAY (SM04690) AS
A POTENTIAL DISEASE
MODIFYING TREATMENT FOR
KNEE OSTEOARTHRITIS.
OP0073
Thursday
09.06.2016
11:10
Cell-cell
interaction in joint
inflammation
Capital Suite
06
Schoenfeld C.
(Germany)
RNA-SEQ BASED
IDENTIFICATION OF FACTORS
INVOLVED IN KNEE JOINT
REGENERATION AFTER
INDUCED OSTEOARTHRITIS IN
NOTOPHTALMUS
VIRIDESCENS.
SP0177
Saturday
11.06.2016
08:35
Cell-cell
interaction in joint
inflammation
Capital Suite
14
Brahn E.
(United States)
INHIBITORY PATHWAYS OF
SYNOVIAL ANGIOGENESIS.
POSTER
SAT0009
Saturday
11.06.2016
10:20
Poster Tour:
Genomics, genetic
basis of disease
and HLA/T cell
recognition
Poster
Area
Nair N.
(United Kingdom,
Ireland)
INVESTIGATION OF
DIFFERENTIAL METHYLATION
AS A POTENTIAL BIOMARKER
OF METHOTREXATE
RESPONSE IN PATIENTS WITH
RHEUMATOID ARTHRITIS.
SP0194
Saturday
11.06.2016
12:25
Bone and heart:
common
molecular
mechanisms in
osteoporosis and
atherosclerosis
Capital Suite
11
Geusens P.
(Belgium)
DO BONE EROSIONS RESULT
FROM LOCAL SYNOVITIS OR
BONE MARROW EDEMA?
OP0310
Saturday
11.06.2016
13:15
Bone and heart:
common
molecular
mechanisms in
osteoporosis and
atherosclerosis
Capital Suite
11
Barbarroja N.
(Spain)
ASSOCIATION OF NEUTROPHIL
EXTRACELLULAR TRAPS WITH
ATHEROSCLEROSIS IN
RHEUMATOID ARTHRITIS.
Hilfslinien anzeigen über Menu:
Folie in Ursprungsform
Wechsel der Textebene/Formatierungen
Start
PAGE 4
Katrin Thorarinsdottir, MD PhD candidate is a rheumatologist at the Department of Rheumatology at Sahlgrenska University
Hospital, Gothenburg, Sweden. Her research activity mainly focuses on B cells and rheumatoid arthritis.
BASIC RESEARCH II
Immunity, immunology
Katrin Thorarinsdottir
ORAL PRESENTATIONS & POSTERS EULAR 2016 LONDON
MAY-JUNE16
Type, n° Date, time Session Room Author Title
OP0022
Wednesday
08.06.2016
18:05
Nanomedicine in
rheumatology
Capital suite
14
Codullo V.
(Italy)
TARGETING FIBROBLASTOID-LIKE
CELLS BY DRUG LOAD
ENGINEERED GOLD
NANOPARTICLES AS A NOVEL
APPROACH TO ILD-SSC
TREATMENT.
OP0026
Thursday
09.06.2016
09:20
Plasma cells as
key players and
therapeutic
target in
rheumatic
diseases
Capital suite
11
Scherer H.
(Netherlands)
SYNOVIAL FLUID MONONUCLEAR
CELLS PROVIDE AN ENVIRONMENT
FOR LONG-TERM SURVIVAL OF
ANTIBODY SECRETING CELLS AND
PROMOTE THE SPONTANEOUS
PRODUCTION OF ANTI-
CITRULLINATED PROTEIN
ANTIBODIES.
POSTER
THU0001
Thursday
09.06.2016
11:45
Poster Tour:
Immunity in
rheumatic
diseases
Poster
Area
Sacre K.
(France)
TERTIARY LYMPHOID ORGANS IN
TAKAYASU ARTERITIS: ARE
LOCALLY MATURED B CELLS
INVOLVED IN THE PATHOGENESIS?
OP0148
Thursday
09.06.2016
16:50
How cell death
shapes
immunity and
tolerance
Capital Suite
11
Chirivi R.
(Netherlands)
FIRST IN CLASS THERAPEUTIC
ACPA REDUCES INFLAMMATION BY
INHIBITION OF NETOSIS.
OP0206
Friday
10.06.2016
11:30
Novel insights
into B and T cell
immunity in
rheumatic
diseases
S20Renoux F.
(France)
FRA2 IS PLAYING A KEY ROLE IN
THE CONTROL OF TREG
DEVELOPMENT AND
AUTOIMMUNITY.
POSTER
FRI0001
Friday
10.06.2016
11:45
Poster Tour:
Time for some
fun with
molecules
Poster
Area
Cavalli G.
(Italy)
TREATING EXPERIMENTAL
ARTHRITIS WITH THE INNATE
IMMUNE INHIBITOR IL-37 REDUCES
JOINT AND SYSTEMIC
INFLAMMATION.
POSTER
SAT0021
Saturday
11.06.2016
10:15
Poster Tour:
Innate immune
cells coming to
play
Poster
Area
Wohlfahrt T.
(Germany)
TYPE 2 INNATE LYMPHOID CELLS
ARE RAPIDLY AND PERSISTENTLY
RECRUITED IN EXPERIMENTAL
FIBROSIS AND THEIR COUNTS
CORRELATE WITH THE SEVERITY
OF SKIN AND LUNG FIBROSIS IN
SYSTEMIC SCLEROSIS.
POSTER
SAT0027
Saturday
11.06.2016
10:15
Poster Tour:
Innate immune
cells coming to
play
Poster
Area
Young N.
(United States)
INHIBITION OF TLR7 AND TLR8
SIGNALING BY ANTAGONIZING
MICRO-RNA DERIVED FROM
EXTRACELLULAR VESICLES
SUPPRESSES INFLAMMATION IN A
NOVEL HUMAN-MOUSE CHIMERIC
MODEL OF LUPUS.
Hilfslinien anzeigen über Menu:
Folie in Ursprungsform
Wechsel der Textebene/Formatierungen
Start
PAGE 5
RA I
Epidemiology, clinics and non biologics
Marlies van der Goes
ORAL PRESENTATIONS & POSTERS EULAR 2016 LONDON
MAY-JUNE16
Type, n° Date, time Session Room Author Title
OP0177
Thursday
09.06.2016
10:40
Prognosis and
outcome in RAHall B
Haavardsholm EA.
(Norway)
ULTRASOUND IN THE
MANAGEMENT OF RHEUMATOID
ARTHRITIS: RESULTS FROM THE
RANDOMIZED CONTROLLED
ARCTIC TRIAL.
POSTER
THU0078
Thursday
09.06.2016
11:45
Poster Tour:
Comorbidities
update 2016 part 1
Poster
Area
Humphreys JH.
(United Kingdom)
MODERATE ALCOHOL
CONSUMPTION IS NOT
ASSOCIATED WITH SERUM
LIVER ABNORMALITIES IN
PATIENTS WITH RHEUMATOID
ARTHRITIS TAKING
METHOTREXATE: DATA FROM
THE CLINICAL PRACTICE
RESEARCH DATABASE (CPRD).
POSTER
THU0032
Thursday
09.06.2016
11:45
Poster Tour:
Prognosis and
outcome in RA
Poster
Area
Nieuwenhuis WP.
(Netherlands)
DIAGNOSTIC ACCURACY OF
HAND AND FOOT MRI FOR
EARLY RHEUMATOID ARTHRITIS.
OP0141
Thursday
09.06.2016
16:35
Optimization of
MTX in RA
treatment
Hall DFlipo RM.
(France)
WHICH STRATEGIES IN
RHEUMATOID ARTHRITIS
PATIENTS WITH INADEQUATE
RESPONSE TO METHOTREXATE
MONOTHERAPY: THE STRATEGE
STUDY.
OP0173
Friday
10.06.2016
10:40
Epidemiology in
RMDsHall C
Bartlett SJ.
(Canada)
HOW MUCH OF A BARRIER IS
EXCESS WEIGHT AND SMOKING
FOR ACHIEVING SUSTAINED
REMISSION IN EARY RA?
RESULTS FROM THE CANADIAN
EARLY ARTHRITIS COHORT.
OP0259
Friday
10.06.2016
11:00
ComorbiditiesCapital Suite
11
Curtis JR.
(United States)
IMPACT OF SUSTAINED
REMISSION ON RISK INFECTION
IN PATIENTS WITH RHEUMATOID
ARTHRITIS ENROLLED IN A US
REGISTRY.
POSTER
FRI0155
Friday
10.06.2016
11:00
Poster Tour: RA
treatment,
predictors tapering
and biosimilars
Poster
Area
Sigaux J.
(France)
FIFTY PERCENT OF PATIENTS
WHO TAPERED TNF-BLOCKERS
WHILE IN STABLE REMISSION
ARE ABLE TO MAINTAIN A
TAPERED REGIMEN AT 3 YEAR:
LONG TERM FOLLOW-UP
EXTENSION OF THE STRASS
TRIAL.
Marlies van der Goes, MD PhD is a rheumatologist in training at the Department of Rheumatology & Clinical Immunology of
the University Medical Center Utrecht in the Netherlands. Her research focuses on rheumatoid arthritis and glucocorticoid
therapy. She is the EMEUNET Country Liaison for the Netherlands.
Hilfslinien anzeigen über Menu:
Folie in Ursprungsform
Wechsel der Textebene/Formatierungen
Start
PAGE 6
Meghna Jani, MRCP MSc PhD in an NIHR clinical lecturer at the ARUK Centre for Epidemiology and a rheumatology
specialy trainee in Manchester, UK. Her main interests are biomarkers of treatment response, immunogenicity in response to
biologic drugs, drug safety and pharmacoepidemiology.
RA II
Biological therapies: anti-TNF
Meghna Jani
ORAL PRESENTATIONS & POSTERS EULAR 2016 LONDON
MAY-JUNE16
Type, n° Date, time Session Room Author Title
OP
Wednesday
08.06.2016
17:00
Clinical
relevance of
immunogenicity
and therapeutic
drug monitoring
Hall DKvien TK.
(Norway)
BIOSIMILARS: OBSERVATIONAL
REAL-LIFE DATA.
OP0175
Thursday
09.06.2016
10:20
Prognosis and
outcome in RAHall B
Bouman C.
(Netherlands)
RADIOGRAPHIC PROGRESSION IN
RHEUMATOID ARTHRITIS PATIENTS
TAPERING TNFI IS PRIMARILY
DRIVEN BY MEAN DISEASE
ACTIVITY OOVER TIME, NOT SO
MUCH BY FLARING OR LOWER TNFI
EXPOSITION.
POSTER
THU0034
Thursday
09.06.2016
11:45
Poster Tour:
Prognosis and
outcome in RA
Poster
Area
Raynauld JP.
(Canada)
USE OF RITUXIMAB COMPARED TO
ANTI-TNF AGENTS AS SECOND AND
THIRD-LINE THERAPY IN PATIENTS
WITH RHEUMATOID ARTHRITIS. A 6-
YEAR FOLLOW-UP REPORT FROM
THE RHUMADATA CLINICAL
DATABASE AND REGISTRY.
OP0225
Friday
10.06.2016
10:40
Developments
in the treatment
of RA
Hall DGlintborg B.
(Denmark)
THREE MONTHS’ CLINICAL
OUTCOMES FROM A NATIONWIDE
NON-MEDICAL SWITCH FROM
ORIGINATOR TO BIOSIMILAR
INFLIXIMAB IN PATIENTS WITH
INFLAMMATORY ARTHRITIS.
RESULTS FROM THE DANBIO
REGISTRY.
POSTER
FRI0159
Friday
10.06.2016
11:45
Poster Tour: RA
treatment:
Predictors,
tapering and
biosimilars
Poster
Area
Lau A.
(Canada)
PERSISTENCE WITH BIOLOGIC
MONOTHERAPY IN COMPARISON
WITH COMBINATION THERAPY
WITH DISEASE-MODIFYING
ANTIRHEUMATIC DRUGS IN
PATIENTS WITH RHEUMATOID
ARTHRITIS; RESULTS FROM AN
ONTARIO RHEUMATOID ARTHRITIS
COHORT.
POSTER
FRI0154
Friday
10.06.2016
11:45
Poster Tour: RA
treatment:
Predictors,
tapering and
biosimilars
Poster
Area
Holroyd C.
(United Kingdom)
ARE THERE NEGATIVE EFFECTS
ON DISEASE ACTIVITY AND
FUNCTION ASSOCIATED WITH
FAILED ANTI-TNF DOSE
REDUCTION STRATEGIES FOR RA
PATIENTS?
Hilfslinien anzeigen über Menu:
Folie in Ursprungsform
Wechsel der Textebene/Formatierungen
Start
PAGE 7
Richard Conway, MB BCh BAO MRCPI LRCSI CCD, has completed specialist training in rheumatology and general internal
medicine and is currently a vasculitis fellow at St. Vincent’s University Hospital and University College Dublin, Ireland. His
major research interests include giant cell arteritis and meta-analysis.
RA III
Other biologics and new drugs beyond biologics
Richard Conway
ORAL PRESENTATIONS & POSTERS EULAR 2016 LONDON
MAY-JUNE16
Type, n° Date, time Session Room Author Title
OP0159
Thursday
09.06.2016
10:20
New pathways
to treatment
Capital Suite
13
Reddy V.
(United Kingdom)
IMPROVING B-CELL DEPLETION IN
RHEUMATOID ARTHRITIS AND SYSTEMIC
LUPUS ERYTHEMATOSUS: RESISTANCE
TO RITUXIMAB AND THE POTENTIAL OF
OBINUTUZUMAB.
OP0178
Thursday
09.06.2016
10:50
Prognosis and
outcome in RAHall B
Harrold LR.
(United States)
IMPACT OF ANTI-CYCLIC CITRULLINATED
PEPTIDE AND RHEUMATOID FACTOR
STATUS ON RESPONSE TO ABATACEPT
THERAPY: FINDINGS FROM A US
OBSERVATIONAL COHORT.
OP0182
Thursday
09.06.2016
11.30
Prognosis and
outcome in RAHall B
Gerlag D.
(Netherlands)
PREVENTION OF RHEUMATOID
ARTHRITIS BY B CELL DIRECTED
THERAPY IN THE EARLIEST PHASE OF
THE DISEASE: THE PRAIRI STUDY.
POSTER
THU0173
Thursday
09.06.2016
11:45
Poster Tour: RA
treatments - non
biological, small
molecules
Poster
Area
Kavanaugh A.
(United States)
FILGOTINIB (GLPG0634), AN ORAL JAK1
SELECTIVE INHIBITOR IS EFFECTIVE AS
MONOTHERAPY IN PATIENTS WITH
ACTIVE RHEUMATOID ARTHRITIS:
RESULTS FROM A 24-WEEK PHASE 2B
DOSE RANGING STUDY.
OP0228
Friday
10.06.2016
11:10
Developments
in the treatment
of RA
Hall DTakeuchi T.
(Japan)
BARICITINIB DOSE STEP-DOWN
FOLLOWING DISEASE CONTROL IN
PATIENTS WITH RHEUMATOID
ARTHRITIS.
OP0260
Friday
10.06.2016
11:10
ComobiditiesCapital Suite
11
Strangfeld A.
(Germany)
LOWER INTESTINAL PERFORATIONS ARE
MORE FREQUENT AND PRESENT
UNTYPICALLY IN PATIENTS TREATED
WITH TOCILIZUMAB COMPARED TO
OTHER BIOLOGIC OR CONVENTIONAL
SYNTHETIC DMARDS.
POSTER
FRI0199
Friday
10.06.2016
11:45
Poster Tour:
Safety and
efficacy of non-
TNFa blockers
in the treatment
of RA – I
Poster
Area
Behrens F.
(Germany)
RITUXIMAB IN COMBINATION WITH
LEFLUNOMIDE: RESULTS FROM A
MULTICENTER RANDOMIZED PLACEBO
CONTROLLED INVESTIGATOR INITIATED
CLINICAL TRIAL IN ACTIVE RHEUMATOID
ARTHRITIS (AMARA-STUDY).
POSTER
SAT0146
Saturday
11.06.2016
10:15
Poster Tour:
Safety and
efficacy of non
TNFa blockers
in the treatment
of RA – II
Poster
Area
Weinblatt M.
(United States)
EARTH EXPLORER 2, A PHASE IIB
EXPLORATORY STUDY EVALUATING
EFFICACY AND SAFETY OF
MAVRILIMUMAB, A FULLY HUMAN
GRANULOCYTE-MACROPHAGE COLONY-
STIMULATING FACTOR RECEPTOR-
ALPHA MONOCLONAL ANTIBODY, AND
THE TUMOR NECROSIS FACTOR
ANTAGONIST GOLIMUMAB IN
RHEUMATOID ARTHRITIS.
Hilfslinien anzeigen über Menu:
Folie in Ursprungsform
Wechsel der Textebene/Formatierungen
Start
PAGE 8
PSORIATIC ARTHRITIS
Paul Studenic
ORAL PRESENTATIONS & POSTERS EULAR 2016 LONDON
MAY-JUNE16
Type, n° Date, time Session Room Author Title
OP0091
Thursday
09.06.2016
11:30
SpA and PsA
clinical
Capital Suite
11
El Miedany Y.
(United Kingdom)
PSORIATIC ARTHRITIS
COMORBIDITY INDEX:
DEVELOPMENT AND VALIDATION OF
A NEW SPECIFIC TOOL FOR
CLASSIFYING PROGNOSTIC
COMORBIDITY IN PSORIATIC
ARTHRITIS PATIENTS.
OP0127
Thursday
09.06.2016
14:45
Advancements
in the imaging of
PsA
Hall DMerashli M.
(United Kingdom)
LOW FREQUENCY OF US
DETERMINED EROSIONS IN EARLY
PSORIATIC ARTHRITIS: RESULTS
FROM THE LEEDS SPARRO
COHORT.
POSTER
THU0434
Thursday
09.06.2016
All day
Poster Session:
Psoriatic arthritis
Poster
Area
Ritchlin C.
(United States)
SERIOUS INFECTIONS IN PSORIASIS
PATIENTS WITH PSORIATIC
ARTHRITIS IN THE PSORIASIS
LONGITUDINAL ASSESSMENT AND
REGISTRY STUDY.
POSTER
THU0444
Thursday
09.06.2016
All day
Poster Session:
Psoriatic arthritis
Poster
Area
Eder L.
(Canada)
SUBCLINICAL ULTRASONOGRAPHIC
ENTHESITIS IN PATIENTS WITH
PSORIASIS IS ASSOCIATED WITH
RISK MARKERS FOR PSORIATIC
ARTHRITIS.
POSTER,
THU0428
Thursday
09.06.2016
All day
Poster Session:
Psoriatic arthritis
Poster
Area
Pfeil A.
(Germany)
PSORIASIS ARTHRITIS IS
ASSOCIATED WITH PERIARTICULAR
BONE LOSS OF THE METACARPALS.
OP0108
Friday
10.06.2016
10:20
Expanding
therapeutic
options in
spondyloarthritis
Hall BGlatt S.
(United Kingdom)
BIMEKIZUMAB, A MONOCLONAL
ANTIBODY THAT INHIBITS BOTH IL-
17A AND IL-17F, PRODUCES A
PROFOUND RESPONSE IN BOTH
SKIN AND JOINTS: RESULTS OF AN
EARLY-PHASE, PROOF-OF-
CONCEPT STUDY IN PSORIATIC
ARTHRITIS.
POSTER
FRI0446
Friday,
10.06.2016
11:45
Poster Session:
Psoriatic arthritis
Poster
Area
Thaçi D.
(Germany)
TREATMENT WITH TILDRAKIZUMAB,
AN ANTI-IL-23P19 MONOCLONAL
ANTIBODY, IMPROVES HEALTH-
RELATED QUALITY OF LIFE IN
PATIENTS WITH CHRONIC PLAQUE
PSORIASIS.
Paul Studenic, MD is a medical resident and clinical research fellow at the Division of Rheumatology of the Medical
University Vienna in Austria. His main interests are outcomes assessment in RA and PsA, patient reported outcomes,
predictors of disease activity, biomarkers and elderly patients. He is currently engaged in the EMEUNET Social Media
Subgroup.
Hilfslinien anzeigen über Menu:
Folie in Ursprungsform
Wechsel der Textebene/Formatierungen
Start
PAGE 9
João Madruga Dias, MD is a rheumatology consultant at Centro Hospitalar Médio Tejo (Portugal) with a special interest in
inflammatory rheumatic diseases, pregnancy, musculoskeletal ultrasound and arthroscopy. He trained arthroscopy in Saint
Vincent’s University Hospital, University College of Dublin. He is a member of the board of the Rheumatology College of the
Portoguese Medical Association and the Portuguese representative at UEMS (European Union of Medical Specialists).
AXIAL SPONDYLOARTHRITIS
João Madruga Dias
ORAL PRESENTATIONS & POSTERS EULAR 2016 LONDON
MAY-JUNE16
Type, n° Date, time Session Room Author Title
OP0086
Thursday
09.06.2016
10:40
SpA and PsA
clinical
Capital Suite
11
Baraliakos X.
(Germany)
WHICH CELLS CORRESPOND TO THE
TYPICAL SIGNALS FOR FATTY AND
INFLAMMATORY LESIONS SEEN IN
MAGNETIC RESONSNCE IMAGING IN
ANKYLOSING SPONDYLITIS? A
PROSPECTIVE STUDY USING BIOPSY
MATERIAL OBTAINED DURING SPINAL
SURGERY.
OP0080
Thursday
09.06.2016
11:00
SpA and PsA basic
and translational
research
Capital Suite
11Poddubnyy D.
(Germany)
HIGH SERUM LEVEL OF LEPTIN MIGHT
BE RESPONSIBLE FOR LESS
STRUCTURAL DAMAGE IN THE SPINE IN
FEMALE PATIENTS WITH ANKYLOSING
SPONDYLITIS.
OP0082
Thursday
09.06.2016
11:20
SpA and PsA basic
and translational
research
Capital Suite
11
Lindström U.
(Sweden)
INFECTIONS OF THE GUT, UROGENITAL
AND RESPIRATORY TRACT AND
APPENDICITIS DURING CHILDHOOD,
AND THE RISK OF DEVELOPING
ANKYLOSING SPONDYLITIS.
OP0231
Friday
10.06.2016
10:20
Emerging concepts
in genomics &
genetics
Capital Suite
06
Roberts AR.
(United Kingdom)
DIFFERENTIAL TRANSCRIPTION
FACTOR BINDING COULD EXPLAIN THE
GENETIC ASSOCIATION OF
ANKYLOSING SPONDYLITIS WITH
POLYMORPHISMS IN THE IL-23R-
IL12RB2 INTERGENIC REGION.
OP0112
Friday
10.06.2016
11:00
Expanding
therapeutic options
in spondyloarthritis
Hall BSepriano A.
(Portugal)
EFFECT OF COMEDICATION WITH
CONVENTIONAL SYNTHETIC DMARDS
ON TNF INHIBITORS RETENTION IN
PATIENTS WITH SPONDYLOARTHRITIS:
A PROSPECTIVE COHORT.
POSTER
FRI0396
Friday
10.06.2016
11:50
Poster Tour: SPA-
clinical
Poster
Area
Baraliakos X.
(Germany)
WHICH IS THE MOST RELIABLE
IMAGING METHOD FOR DETECTION OF
STRUCTURAL CHANGES IN THE
SACROILIAC JOINTS OF PATIENTS WITH
ANKYLOSING SPONDYLITIS? A CROSS-
SECTIONAL STUDY COMPATING MRI,
CT AND CONVENTIONAL
RADIOGRAPHS.
POSTER
SAT0372
Saturday
11.06.2016
10:20
Poster Tour:
Optimising
treatment of axial
SpA
Poster
Area
Park JW.
(Korea)
IMPACT OF DOSE TAPERING OF
TUMOUR NECROSIS FACTOR-
BLOCKERS ON RADIOGRAPHIC
PROGRESSION IN THE ANKYLOSING
SPONDYLITIS-A 4 YEAR PROSPECTIVE
FOLLOW-UP FROM SINGLE CENTRE
COHORT.
Hilfslinien anzeigen über Menu:
Folie in Ursprungsform
Wechsel der Textebene/Formatierungen
Start
PAGE 10
Jan Leipe, MD has completed specialist training in rheumatology and general internal medicine and is currently an attending
physician at University of Munich, Germany. His major research interests include early RA and the role of T cells in the
pathogenesis of autoimmune arthritis.
SLE & APS
Jan Leipe
ORAL PRESENTATIONS & POSTERS EULAR 2016 LONDON
MAY-JUNE16
Type, n° Date, time Session Room Author Title
OP0042
Thursday
09.06.2016
10:50
Advances in SLE
TherapeuticsHall D
Md Yusof Md Y.
(United Kingdom)
HUMANISED ANTI-CD20 ANTIBODIES
IMPROVE DEPLETION AND
RESPONSE IN SLE PATIENTS WITH
RESISTANCE TO RITUXIMAB:
RESULTS FROM THE FIRST 100
PATIENTS AT A SINGLE CENTRE.
POSTER
THU0250
Thursday
09.06.2016
11:45
Poster Tour: Walk
through new
pathways,
biomarkers and
potential
treatments in SLE
and Sjögren’s
Poster
Area
Chiche L.
(France)
DYSREGULATION OF AUTOPHAGY IN
SYSTEMIC LUPUS ERYTHEMATOSUS
IS CORRELATED TO
TRANSCRIPTIONAL INTERFERON
SIGNATURES AND PROVIDES
CANDIDATE BIOMARKERS.
POSTER
FRI0309
Friday
10.06.2016
10:15
Poster Tour: SLE
and APS-Clinical
aspects
Poster
Area
Mohamed A.
(United Kingdom)
TYPE I INTERFERON ACTIVITY IS
ASSOCIATED WITH
MUCOCUTANEOUS BUT NOT
MUSCULOSKELETAL DISEASE
ACTIVITY IN SYSTEMIC LUPUS
ERYTHEMATOSUS.
POSTER
FRI0313
Friday
10.06.2016
10:15
Poster Tour: SLE
and APS-Clinical
aspects
Poster
Area
Riancho-Zarrabeitia L.
(Spain)
EVALUATION OF THROMBOTIC RISK
IN PATIENTS WITH POSITIVE
ANTIPHOSPHOLIPID ANTIBODIES
WITHOUT CLINICAL CRITERIA OF THE
DISEASE.
OP0183
Friday
10.06.2016
10:30
SLE, Sjögren's
and APS: clinical
aspects
Hall ADurcan L.
(United States)
HYPOCOMPLEMENTEMIA
ASSOCIATES WITH THROMBOSIS IN
SLE PATIENTS WITH
ANTIPHOSPHOLIPID ANTIBODIES.
POSTER
FRI0314
Friday
10.06.2016
11:45
Poster Tour: SLE
and APS-Clinical
aspects
Poster
Area
Zuily S.
(France)
ANTIPHOSPHOLIPID SYNDROME
ALLIANCE FOR CLINICAL TRIALS AND
INTERNATIONAL NETWORKING (APS
ACTION) CLINICAL DATABASE AND
REPOSITORY ANALYSIS: THE IMPACT
OF SYSTEMIC LUPUS
ERYTHEMATOSUS ON THE CLINICAL
PHENOTYPE OF ANTIPHOSPHOLIPID
ANTIBODY-POSITIVE PATIENTS.
OP0291
Saturday
11.06.2016
09:47
Session: SLE:
What will it be
and how will it be
treated 5 years
from now
Hall DFurie R.
(United States)
ANIFROLUMAB, AN ANTI-
INTERFERON-ALPHA RECEPTOR
MONOCLONAL ANTIBODY, IN
MODERATE TO SEVERE SYSTEMIC
LUPUS ERYTHEMATOSUS (SLE).
POSTER
SAT0285
Saturday
11.06.2016
All day
Poster Tour: SLE
and Sjögren’s-
Clinical aspects
Poster
Area
Chehab G.
(Germany)
VACCINATIONS IN SLE: COVERAGE
AND REASONS FOR NON-
VACCINATION - RESULTS FROM THE
LULA-STUDY.
Hilfslinien anzeigen über Menu:
Folie in Ursprungsform
Wechsel der Textebene/Formatierungen
Start
PAGE 11
OTHER CONNECTIVE TISSUE DISEASES
Including systemic sclerosis, myositis, vasculitis
Barbara Ruaro
ORAL PRESENTATIONS & POSTERS EULAR 2016 LONDON
MAY-JUNE16
Type, n° Date, time Session Room Author Title
OP0053
Thursday
09.06.2016
10:20
Vasculitis Hall AYates M.
(United Kingdom)
EULAR/ERA-EDTA
RECOMMENDATIONS FOR THE
MANAGEMENT OF ANCA-
ASSOCIATED VASCULITIS.
OP0038
Thursday
09.06.2016
11:40
Diagnosis and
management of
SSc
Hall CLi L.
(Canada)
IMPROVED SURVIVAL IN
DERMATOMYOSITIS AND
POLYMYOSITIS: A GENERAL
POPULATION-BASE STUDY.
OP0045
Friday
10.06.2016
10:20
Scleroderma,
myositis and
related
conditions
Capital Suite
01
Schniering J.
(Switzerland)
EARLY DETECTION OF LUNG
INVOLVEMENT IN SYSTEMIC
SCLEROSIS USING MOLECULAR
TARGETED IMAGING.
POSTER
FRI0252
Friday
10.06.2016
11:45
Poster Tour:
Scleroderma,
myositis and
related
syndromes I
Poster
Area
Khanna D.
(United States)
EFFICACY OF MYCOPHENOLATE
MOFETIL (MMF) VERSUS ORAL
CYCLOPHOSPHAMIDE (CYC) ON SKIN
THICKNESS IN THE SCLERODERMA
LUNG STUDY II.
POSTER
FRI0238
Friday
10.06.2016
11:45
Poster Tour:
From research
to biomarkers
and targeting
SSc
Poster
Area
Bosello S.
(Italy)
INCREASED SERUM FREE LIGHT
CHAINS OF IMMUNOGLOBULINS IN
SYSTEMIC SCLEROSIS PATIENTS:
CORRELATION WITH LUNG
INVOLVEMENT AND INFLAMMATORY
MILIEU.
POSTER
FRI0239
Friday
10.06.2016
11:45
Poster Tour:
From research
to biomarkers
and targeting
SSc
Poster
Area
Abignano G.
(United Kingdom)
COMPLEMENTARY VALUE OF ELF
TEST AND NT-PROBNP IN
REFLECTING FIBROSIS AND
VASCULOPATHY IN SYSTEMIC
SCLEROSIS.
OP0289
Friday
10.06.2016
16:35
Potential targets
in inflammatory
fibrotic
conditions in
SSc
Capital Suite
14
Rudnik M.
(Switzerland)
MICRORNAS AS POTENTIAL
REGULATORS OF MONOCYTE
DIFFERENTIATION AND FUNCTION IN
HEART FIBROSIS IN SYSTEMIC
SCLEROSIS.
POSTER
SAT0195
Saturday
11.06.2016
10:15
Poster Tour:
Scleroderma,
myositis and
related
syndromes II
Poster
Area
Felis-Giemza A.
(Poland)
EARLY NAILFOLD CAPILLAROSCOPIC
PATTERN PREDOMINATES IN
PATIENTS WITH MIXED CONNECTIVE
TISSUE DISEASE.
Barbara Ruaro, MD currently works in the Research Laboratory and Academic Division of Clinical Rheumatology,
Department of Internal Medicine, University of Genova, Italy. Her interests are connective tissue diseases, spondyloarthritis
and ultrasonography in rheumatology.
Hilfslinien anzeigen über Menu:
Folie in Ursprungsform
Wechsel der Textebene/Formatierungen
Start
PAGE 12
Christian Dejaco, MD PhD MBA is a consultant and associate professor at the Medical University Graz. His main research
interests are the value of ultrasound in psoriatic arthritis and vasculitis, clinical research on polymyalgia rheumatica and
translational research on T lymphocyte senescence in rheumatology. He is the country liaison for EMEUNET in Austria.
IMAGING
Christian Dejaco
ORAL PRESENTATIONS & POSTERS EULAR 2016 LONDON
MAY-JUNE16
Type, n° Date, time Session Room Author Title
OP0177
Thursday
09.06.2016
10:40
Prognosis and
outcome in RAHall B
Haavardsholm EA.
(Norway)
ULTRASOUND IN THE MANAGEMENT OF
RHEUMATOID ARTHRITIS: RESULTS
FROM THE RANDOMIZED CONTROLLED
ARCTIC TRIAL.
OP0124
Thursday
09.06.2016
11:20
New insights
into imagingS20
Glimm AM.
(Germany)
IMAGING REMISSION BY
MUSCULOSKELETAL ULTRASOUND
LEADS TO A BETTER FUNCTIONAL
OUTCOME – RESULTS OF THE US
IMPERA STUDY - US 7-SCORE
IMPLEMENTATION STUDY IN EARLY
RHEUMATOID ARTHRITIS.
POSTER
FRI0514
Friday
10.06.2016
11:45
Poster Tour:
Imaging in
RMD-Adding
value
Poster
Area
Ez-Zaitouni Z.
(Netherlands)
ADDING MRI OF THE SPINE TO THE
ASAS CLASSIFICATION CRITERIA FOR
AXIAL SPONDYLOARTHRITIS,
REDUNDANT OR BENEFICIAL? DATA
FROM THE SPONDYLOARTHRITIS
CAUGHT EARLY (SPACE)-COHORT.
OP0266
Friday
10.06.2016
14:45
The role of
nuclear
medicine in
rheumatology
Hall CBruijnen S.
(Netherlands)
BASELINE 89ZR-RITUXIMAB PET MAY
PREDICT THERAPEUTIC RESPONSE 24
WEEKS AFTER INITIATION OF
RITUXIMAB TREATMENT IN
RHEUMATOID ARTHRITIS PATIENTS.
POSTER
FRI0546
Friday
10.06.2016
All day
Poster Session:
Diagnostic and
imaging
procedures
Poster
Area
Husic R.
(Austria)
THE POWER DOPPLER RESULT IN
RHEUMATOID ARTHRITIS DEPENDS ON
THE POSITION OF HANDS DURING
ULTRASOUND EXAMINATION.
OP0292
Saturday
11.06.2016
09.35
Clinical
outcomes for
PMR / GCA
Hall AKume K.
(Japan)
INTERSPINOUS BURSITIS EVALUATION
BY ULTRASOUND IS VERY USEFUL FOR
DIAGNOSIS OF POLYMYALGIA
RHEUMATICA.
POSTER
SAT0216
Saturday
11.06.2016
All day
Poster session:
Scleroderma,
myositis and
related
syndromes
Poster
Area
Rotondo C.
(Italy)
CHEST ULTRASOUND SIGNS OF
INTERSTITIAL LUNG DISEASE IN
SYSTEMIC SCLEROSIS PATIENTS: A
COMPARISON BETWEEN HIGH
RESOLUTION CHEST COMPUTED
TOMOGRAPHY FINDINGS.
POSTER
SAT0541
Saturday
11.06.2016
All day
Poster Session:
Diagnostic and
imaging
procedures
Poster
Area
Latourte A.
(France)
MORE THAN HALF OF DIFFUSE
IDIOPATHIC SKELETAL HYPEROSTOSIS
PATIENTS MAY FULFILL THE ASAS
DEFINITION OF A POSITIVE MRI OF THE
SPINE: A RETROSPECTIVE ANALYSIS
OF 53 CASES.
Hilfslinien anzeigen über Menu:
Folie in Ursprungsform
Wechsel der Textebene/Formatierungen
Start
PAGE 13
Marie Kostine, MD is a clinical fellow in Rheumatology at Bordeaux Hospital, France. She is currently working as a PhD
candidate at the Leiden University Medical Center, Netherlands, on immune infiltrate in bone and soft-tissue tumours.
OSTEOARTHRITIS & OSTEOPOROSIS
Marie Kostine
ORAL PRESENTATIONS & POSTERS EULAR 2016 LONDON
MAY-JUNE16
Type, n° Date, time Session Room Author Title
OP0069
Thursday
09.06.2016
10:30
Cartilage, bone,
synovium
Capital Suite
06
Hood J.
(USA)
DISCOVERY OF A SMALL
MOLECULE INHIBITOR OF THE
WNT PATHWAY (SM04690) AS A
POTENTIAL DISEASE MODIFYING
TREATMENT FOR KNEE
OSTEOARTHRITIS.
OP0101
Thursday
09.06.2016
10:30
Clinical
osteoporosis:
new insights
Capital Suite
02
Sokal A.
(France)
BISPHOSPHONATES DURING
PREGNANCY: A PROSPECTIVE
STUDY.
OP0098
Thursday
09.06.2016
11:20
New horizons in
osteoarthritis
Capital Suite
14
Kroon F.
(Netherlands)
EFFECT OF ETANERCEPT ON
SYNOVITIS AND BONE MARROW
LESIONS IN EROSIVE HAND
OSTEOARTHRITIS.
OP0135
Thursday
09.06.2016
14:45
Lubricants:
potential as
osteoarthritis
treatment?
Capital Suite
14
Eymard F.
(France)
PREDICTIVE FACTORS OF
FAILURE OF
VISCOSUPPLEMENTATION IN
PATIENTS WITH KNEE
OSTEOARTHRITIS. RESULTS OF
A POST-HOC ANALYSIS OF A
DOUBLE BLIND, CONTROLLED
NON INFERIORITY TRIAL.
OP0143
Thursday
09.06.2016
16:35
Joint
replacement in
OA: Friend or
Foe?
Hall CAitken D.
(Australia)
THE EFFECT OF PHYSICAL
ACTIVITY ON THE RISK OF TOTAL
JOINT REPLACEMENT FOR
SEVERE KNEE OR HIP
OSTEOARTHRITIS: A
POPULATION-BASED
PROSPECTIVE COHORT STUDY.
POSTER
SAT0430
Saturday
11.06.2016
10:15
Poster Tour:
New insights in
osteoarthritis
Poster
Area
Magnusson K.
(Norway)
NEITHER OBESITY, SMOKING
AND ALCOHOL ARE ASSOCIATED
WITH HAND OSTEOARTHRITIS-
LONGITUDINAL DATA FROM
OSTEOARTHRITIS INITIATIVE
(OAI).
OP0306
Saturday
11.06.2016
13:20
Paget’s and
other rare bone
diseases
Hall CPapapoulos S.
(Netherlands)
TEN YEARS OF DENOSUMAB
TREATMENT IN
POSTMENOPAUSAL WOMEN
WITH OSTEOPOROSIS: RESULTS
FROM THE FREEDOM
EXTENSION TRIAL.
Hilfslinien anzeigen über Menu:
Folie in Ursprungsform
Wechsel der Textebene/Formatierungen
Start
PAGE 14
Mike Becker, MD is a board certified rheumatologist and has been a clinical and research fellow in the Department of
Rheumatology and Clinical Immunology at the Charité Medical Faculty in Berlin, Germany, until 2016 and recently joined the
Department of Rheumatology at the University Hospital Zürich, Switzerland. interests are connective tissue diseases,
especially systemic sclerosis.
METABOLIC & CRYSTAL ARTHROPATHIES
Mike Becker
ORAL PRESENTATIONS & POSTERS EULAR 2016 LONDON
MAY-JUNE16
Type, n° Date, time Session Room Author Title
OP0017
Wednesday
08.06.2016
18:05
Outcome measures
in clinical practice in
gout and CPPD. The
use of the new
EULAR guidelines
Hall A Scheepers LE.
(Netherlands)
MEDICATION TAKING
BEHAVIOUR OF ALLOPURINOL
TREATMENT AMONG PATIENTS
WITH GOUT: A RETROSPECTIVE
COHORT STUDY IN THE
CLINICAL PRACTICE RESEARCH
DATALINK (CPRD).
OP0018
Wednesday
08.06.2016
18:05
Outcome measures
in clinical practice in
gout and CPPD. The
use of the new
EULAR guidelines
Hall A Nossent J.
(Australia)
HYPERURICEMIA INCREASES
MORTALITY ONLY IN PATIENTS
WITH GOUT AND EXISTING
CARDIOVASCULAR DISEASE. A
PROSPECTIVE ANALYSIS FROM
THE BUSSELTON HEALTH
STUDY.
POSTER
THU0498
Thursday
09.06.2016
11:45
Poster Tour: Crystal
and metabolic bone
diseases; bone
diseases other than
osteoporosis
Poster
Area
Fransen J.
(Netherlands)
GENDER DIFFERENCES IN THE
PHENOTYPE OF GOUT AND ITS
EFFECT ON CLASSIFICATION
USING THE ACR-EULAR
CRITERIA.
POSTER
THU0524
Thursday
09.06.2016
All day
Poster session:
Crystal disease,
metabolic bone
diseases and bone
diseases other than
osteoporosis
Poster
Area
Frallonardo P.
(Italy)
THE EFFECTIVENESS OF
METHOTREXATE IN PATIENTS
WITH RESISTANT CHRONIC
CALCIUM PYROPHOSPHATE
CRYSTAL ARTHRITIS.
POSTER
THU0527
Thursday
09.06.2016
All day
Poster session:
Crystal disease,
metabolic bone
diseases and bone
diseases other than
osteoporosis
Poster
Area
Khanna PP.
(USA)
LESINURAD, A SELECTIVE URIC
ACID REABSORPTION
INHIBITOR, IN COMBINATION
WITH XANTHANE OXIDASE
INHIBITORS: SUA AND FLARES
COMPOSITE ENDPOINT FROM
PHASE III STUDIES IN GOUT
PATIENTS (CLEAR 1, CLEAR 2
AND CRYSTAL).
OP0287
Friday
10.06.2016
16:35
Inflammasome as
therapeutic target in
inflammatory
diseases-
Capital Suite
11
Campillo-Gimenez L.
(France)
CALCIUM PYROPHOSPHATE
DIHYDRATE CRYSTALS INDUCE
IL-1Β PRODUCTION BY
MONOCYTES THROUGH A
POTASSIUM EFFLUX-
DEPENDENT PATHWAY.
POSTER
SAT0542
Saturday
11.06.2016
All day
Poster session:
Diagnostic and
imaging procedures
Poster
Area
Toscano C.
(Italy)
THE PREVALENCE OF CALCIUM
PYROPHOSPHATE DEPOSITS AT
ULTRASOUND EXAMINATION:
RETROSPECTIVE ANALYSIS IN A
COHORT OF PATIENTS.
Hilfslinien anzeigen über Menu:
Folie in Ursprungsform
Wechsel der Textebene/Formatierungen
Start
PAGE 15
PEDIATRIC RHEUMATOLOGY
W. Alberto Sifuentes Giraldo
ORAL PRESENTATIONS & POSTERS EULAR 2016 LONDON
MAY-JUNE16
Type, n° Date, time Session Room Author Title
OP0012
Wednesday
08.06.2016
16:15
Lessons from
the children
(monogenic
causes of
autoimmunity)
Capital Suite
02
Thornton S.
(United States)
MICRORNA ASSOCIATED WITH
ACTIVE SYSTEMIC JUVENILE
IDIOPATHIC ARTHRITIS
REGULATE CD163
EXPRESSION IN POLARIZED
MACROPHAGES THROUGH
TWO DISTINCT MECHANISMS.
POSTER
THU0221
Thursday
09.06.2015
11:45
Poster Tour:
Arthritis in
childhood
Poster
Area
Aktay Ayaz N.
(Turkey)
EFFICACY OF BIOLOGICAL
AGENTS IN COLCHICINE
RESISTANT CHILDREN WITH
FMF.
OP0215
Friday
10.06.2016
10:20
Advances in
pediatric
rheumatology
Capital Suite
02
Ruperto N.
(Italy)
SUBCUTANEOUS ABATACEPT
IN PATIENTS WITH
POLYARTICULAR JUVENILE
IDIOPATHIC ARTHRITIS AND
INADEQUATE RESPONSE TO
BIOLOGIC OR NON-BIOLOGIC
DISEASE-MODIFYING
ANTIRHEUMATIC DRUGS:
PHARMACOKINETICS,
EFFICACY AND SAFETY.
OP0221
Friday
10.06.2016
11:20
Prognosis and
outcome in RA
Capital Suite
02
Campanilho-Marques R.
(United Kingdom)
EFFICACY AND SAFETY OF
TUMOUR NECROSIS FACTOR-Α
ANTAGONISTS IN A LARGE
COHORT OF JUVENILE
DERMATOMYOSITIS PATIENTS.
OP0275
Friday
10.06.2016
14:45
Role of imaging
in childhood-
onset rheumatic
diseases
Capital Suite
02
Collado P.
(Spain)
PREVALENCE OF
ULTRASOUND-DETECTED
FINDINGS IN FOOT IN
JUVENILE IDIOPATHIC
ARTHRITIS VERSUS HEALTHY
CHILDREN: ASSOCIATION TO
PAEDIATRIC FOOT POSTURE.
POSTER
SAT0254
Saturday
11.06.2015
10:15
Poster Tour:
Juvenile-onset
connective
tissue diseases
Poster
Area
Sezgin S.
(Turkey)
THE ICEBERG IN JUVENILE
ONSET SYSTEMIC LUPUS
ERYTHEMATOSUS:
SUBCLINICAL DETERIORATION
OF CARDIAC FUNCTIONS
ASSESSED WITH TWO-
DIMENSIONAL SPECKLE
TRACKING
ECHOCARDIOGRAPHY AND
CONTRIBUTING FACTORS OF
SYSTOLIC DYSFUNCTION.
W. Alberto Sifuentes Giraldo, MD is a research associate at the Department of Rheumatology of the University Hospital
Ramon y Cajal, Madrid, Spain. His main research interest focuses on pediatric rheumatology, spondyloarthritis and biological
therapies.
Hilfslinien anzeigen über Menu:
Ursprungsform
im Menü über:
Start | Absatz | Listenebene
THE YOUNG RHEUMATOLOGIST SESSIONS
PAGE 16
Wednesday 08.06.2016
15:00 - 16:30
Wednesday 08.06.2016
17:00 - 18:30
THE YOUNG RHEUMATOLOGIST
SESSIONS (1)
ABC of statistics
Chair: Aletaha Daniel (Austria)
Chair: Ramiro Sofia (Netherlands)
Speaker: Michaud Kaleb (United States) STATISTICS IN RESEARCH IN
RHEUMATOLOGY - HOW TO MAKE THE BEST USE OF IT?
Speaker: Norton Sam (United Kingdom) SP0026 THE BASICS OF A
REGRESSION ANALYSIS
Speaker: Carmona Loreto (Spain) SP0027 CONFOUNDING - FRIEND OR
FOE? HOW TO HANDLE?
Abstract: Sergeant Jamie (United Kingdom) OP0013 PREDICTION OF NON-
RESPONSE TO METHOTREXATE THERAPY IN THE RHEUMATOID
ARTHRITIS MEDICATION STUDY (RAMS)
Beyond EMEUNET: development of a European-wide network of young
clinicians from different specialties focusing on inflammatory diseases
Chair: Gossec Laure (France)
Chair: Richez Christophe (France)
Speaker: Moltó Anna (France) SP0053 EXPERIENCES FROM YOUNG
RHEUMATOLOGISTS INTO EMEUNET
Speaker: Hindryckx Pieter (Canada) SP0054 EXPERIENCES FROM YOUNG
GASTROENTEROLOGISTS INTO Y-ECCO
Speaker: Smith Eve (United Kingdom) SP0055 EXPERIENCES FROM
YOUNG REPRESENTATIVE OF PAEDIATRIC RHEUMATOLOGY
EUROPEAN SOCIETY
Speaker: da Costa Ferreira Ana Carina (Portugal) SP0056 EXPERIENCES
FROM THE YOUNG NEPHROLOGISTS’ PLATFORM
MAY-JUNE16
All sessions will be held in Capital Suite 01
Hilfslinien anzeigen über Menu:
Ursprungsform
im Menü über:
Start | Absatz | Listenebene
THE YOUNG RHEUMATOLOGIST SESSIONS
PAGE 17
Thursday 09.06.2016
13:30-15:00
Thursday 09.06.2016
15:30-17:00
THE YOUNG RHEUMATOLOGIST
SESSIONS (2)
The elephant in the room: how to avoid biases in research?
Chair: Boers Maarten (Netherlands)
Chair: Aydin Sibel Zehra (Turkey)
Speaker: Aletaha Daniel (Austria) RISK OF BIAS WHEN DESIGNING A TRIAL
Speaker: Landewé Robert B.M. (Netherlands) RISK OF BIAS WHEN CONDUCTING A
TRIAL
Speaker: Yazici Hasan (Turkey) SP0090 RISK OF BIAS WHEN REPORTING A TRIAL
Presenter: Sepriano Alexandre (Portugal) EFFECT OF COMEDICATION WITH
CONVENTIONAL SYNTHETIC DMARDS ON TNF INHIBITORS-RETENTION IN
PATIENTS WITH SPONDYLOARTHRITIS: A PROSPECTIVE COHORT
Abstract: Richter Adrian (Germany) OP0138 SIMPLE POOLING OF DATA FROM
DIFFERENT STUDIES IS INCREASINGLY USED BUT NOT IN LINE WITH
METHODOLOGICAL RECOMMENDATIONS: A SYSTEMATIC REVIEW
OF METHODS APPLIED IN THE FIELD OF RHEUMATOID ARTHRITIS
MAY-JUNE16
Teaching clinical skills
Chair: Doherty Michael (United Kingdom)
Chair: Romao Vasco C (Portugal)
Speaker: Doherty Michael (United Kingdom) SP0109 HOW TO PERFORM CLINICAL
HISTORY AND PHYSICAL EXAMINATION?
Speaker: Caporali Roberto (Italy) HOW TO READ A PLAIN JOINT X-RAY?
Speaker: Hafler Janet (United States) SP0110 THE ART OF TEACHING
RHEUMATOLOGY: TIPS AND TRICKS
Presenter: Kosevoi Alexandra (Romania) RELATIONSHIP BETWEEN ULTRASOUND-
DETECTED SYNOVITIS, QUALITY OF LIFE AND WORK PRODUCTIVITY IN
PATIENTS WITH RHEUMATOID ARTHRITIS OF WORKING AGE
Abstract: Sukhdeo Aishwarya (Australia) OP0151 A STUDY ON MEDICAL STUDENTS
LEARNING ULTRASOUND IN RHEUMATOID ARTHRITIS (ASMSLURA)
Hilfslinien anzeigen über Menu:
Ursprungsform
im Menü über:
Start | Absatz | Listenebene
THE YOUNG RHEUMATOLOGIST SESSIONS
PAGE 18
Friday 10.06.2015
13:30-15:00
Friday 10.06.2015
15:30-17:00
THE YOUNG RHEUMATOLOGIST
SESSIONS (3)
Chair: Skingle Diana (United Kingdom)
Chair: Alunno Alessia (Italy)
Speaker: Nikiphorou Elena (United Kingdom) SP0141 THE POINT OF VIEW OF
PHYSICIAN. SOCIAL MEDIA: PROS AND CONS OF SHARING PATIENT AND
PHYSICIAN PERSONAL EXPERIENCE
Speaker: van Nieuwkoop Linda (Netherlands) THE POINT OF VIEW OF PATIENTS.
ROLE OF INTERACTIVE MEDIA IN ACCESSING MEDICAL INFORMATION AND IN
BUILDING PATIENT-PHYSICIAN RELATIONSHIP
Faculty: INTERACTIVE OPEN DISCUSSION
Abstract: Vliet Vlieland Theodora (Netherlands) OP0276 POSTGRADUATE
RHEUMATOLOGY EDUCATION FOR HEALTH PROFESSIONALS IN
RHEUMATOLOGY: AVAILABILITY, NEEDS AND BARRIERS
Abstract: Clausen Jürgen (Germany) OP0277-PARE PATIENT RESEARCH
PARTNERS INVOLVED IN A PROJECT TO ENHANCE DISEASEASSOCIATED
COMMUNICATIONS SKILLS OF RHEUMATOID PATIENTS.
Physician-patient relationship in the era of interactive media
How to get into the international world of rheumatology
Chair: Sivera Francisca (Spain)
Chair: Ramiro Sofia (Netherlands)
Speaker: Moltó Anna (France) THE ROLE OF EMEUNET
Speaker: Machado Pedro (Portugal) OPPORTUNITIES ABROAD
Speaker: Dougados Maxime (France) COLLABORATIVE EU PROJECTS – HOW TO
GET INVOLVED?
Presenter: Fragoulis George E. (Greece) SICCA SYMPTOMS IN RHEUMATOID
ARTHRITIS: REAL SJOGREN'S OR NOT?
Presenter: Selickaja Sandra (Lithuania) ANTI-TIF1-GAMMA ANTIBODIES – MARKERS
OF PARANEOPLASTIC MYOSITIS BUT NOT OF PARANEOPLASTIC RHEUMATIC
SYNDROMES OR SOLID TUMORS
MAY-JUNE16
Hilfslinien anzeigen über Menu:
Ursprungsform
im Menü über:
Start | Absatz | Listenebene
THE YOUNG RHEUMATOLOGIST SESSIONS
PAGE 19
Saturday 11.06.2015
08:30-10:00
Saturday 11.06.2015
12:00-13:30
THE YOUNG RHEUMATOLOGIST
SESSIONS (4)
Career paths in research - how to start and where to go?
Chair: Buch Maya (United Kingdom)
Chair: Ramiro Sofia (Netherlands)
Speaker: Askling Johan (Sweden) TESTIMONIES OF CLINICAL RESEARCH
Speaker: Schett Georg (Germany) TESTIMONIES OF BASIC/TRANSLATIONAL
RESEARCH
Speaker: van der Heijde Désirée (Netherlands) THE VIEW AND ADVICE OF AN
EXPERT
Presenter: Fernandes Silvia (Portugal) VITAMIN DEFICIENCY AND DISEASE
ACTIVITY/SEVERITY IN SPONDYLOARTHRITIS: RESULTS OF THE ASAS-
COMOSPA INTERN. STUDY
Presenter: Tombetti Enrico (Italy) TAKAYASU ARTERITIS: CLINIMETRY,
PROGRESSION AND CORONARY INVOLVEMENT
Presenter: Soare Alina (Romania) NEW FIBROSIS MECHANISM IN SYSTEMIC
SCLEROSIS AND POTENTIAL TREATMENT TARGETS
Presenter: Perniola Simone (Italy) SPECIALIZED PRO-RESOLVING MEDIATOR
RECEPTORS IN OSTEOARTHRITIC SYNOVIUM AND CARTILAGE
EULAR educational offer
Chair: Mandl Peter (Austria)
Chair: Sepriano Alexandre (Portugal)
Speaker: Hachulla Eric (France) SP0197 EULAR EDUCATIONAL OFFER: WHERE
ARE WE NOW?
Speaker: Haines Catherine (United Kingdom) SP0198 A MASTERCLASS ON
ASSESSMENT QUESTIONS IN ONLINE COURSES
Speaker: Naredo Esperanza (Spain) SP0199 DEVELOPMENTS IN EULAR
EDUCATIONAL PROJECTS IN ULTRASOUND
Speaker: Iagnocco Annamaria (Italy) SP0200 COMPETENCY ASSESSMENT IN US:
AN EXAMPLE OF QUALIFICATION OFFERED BY EULAR
Faculty: Q&A AND ACTIVE DISCUSSION
MAY-JUNE16
Hilfslinien anzeigen über Menu:
Ursprungsform
im Menü über:
Start | Absatz | Listenebene
EMEUNET SOCIAL EVENTS AT EULAR 2016
PAGE 20
EMEUNET Sightseeing tour of London by
cable car and boat
Thursday 9 June, 5:30 pm
EMEUNET has organized a ride with
breathtaking views of London on the Emirates
cable car, flying from the Royal Docks to North
Greenwich, followed by a boat trip from North
Greenwich to the London Eye. If you missed
the registration meet us later (see below).
Get together at Doggett's coat and badge pub
Thursday 09 June, after the cable car/boat tour
around 8:30 pm
EMEUNET evening is an excellent opportunity
to meet other EMEUNET members and to make
new contacts and friends around the world. Join
us at the Doggett's coat and badge pub, 1
Blackfriars Bridge,London SE1 9UD, London.
The traditional EMEUNET Booth will this
year be located at V31 in the EULAR
Village. As previous years, this will be a key
meeting point for young rheumatologists,
where they can receive information on the
great work of EMEUNET and can be
actively encouraged to sign up. Additionally,
it will also serve as a point of contact for
existing members to come say hello and
meet their fellow members.
EMEUNET BOOTH
MAY-JUNE16
EMEUNET EVENTS AT EULAR 2016
Hilfslinien anzeigen über Menu:
Ursprungsform
im Menü über:
Start | Absatz | Listenebene
YOUR OPINION IS IMPORTANT!
If you are one of the mentees that will participate to the meetings give us your feedback after the
event and it will be included in next Newsletter issue!
EDUCATIONAL ACTIVITIES
PAGE 21
THE MENTOR MENTEE MEETINGS AT EULAR 2016
EMEUNET offers you an unique opportunity to discuss about possible career options, your
research and your involvement in EULAR with leaders in the field in an informal way. Sign up
for the mentor-mentee meetings at EULAR 2016, London. As you all know, one of the missions
of EMEUNET is increasing the mentor-mentee interaction. Previous mentor-mentees meetings
at EULAR and ACR have been very interactive and were scored very satisfactory by mentees.
The next mentor-mentee will take place on Thursday 9th of June at 6 PM in Room S14 and will
last approximately 1 hour. The number of mentees will be limited to 4-6 for each group to enhance
interaction. Here are the 3 professors that will guide as mentors:
PROFESSOR: Alfred Mahr (Hopital Saint-Louis, Paris/France)
AREA: Epidemiology of vasculitis, in particular Churg-Strauss Syndrome
PROFESSOR: . Deborah Symmons (University of Manchester/UK):
AREA: Epidemiology of inflammatory musculoskeletal conditions with emphasis on development
and outcome of rheumatoid arthritis. Clinical trials and drug safety.
PROFESSOR: Philip Conaghan (University of Leeds/UK):
AREA: Translational studies and clinical trials in understanding and treatment of rheumatoid
arthritis, psoriatic arthritis and osteoarthritis
MAY-JUNE16
Hilfslinien anzeigen über Menu:
Ursprungsform
im Menü über:
Start | Absatz | Listenebene
EDUCATIONAL ACTIVITIES
PAGE 22
THE EULAR-EMEUNET AMBASSADOR PROGRAMME
FOR FIRST TIME ATTENDEES
Attending the largest European Rheumatology congress for the first time can be a daunting
experience. The annual EULAR meeting welcomes around 14,000 clinicians and scientists,
discussing clinical management and new scientific findings in an overwhelming number of sessions
which run in parallel, starting early in the morning and ending late at night. There has been a long
tradition that senior attendees share the skills on how to survive the annual EULAR meeting, on
how to get a taste of everything and not miss the important facts, and have a great time. But how
can you find your way through countless opportunities within four days?
We invite 30 fellows who are first or second-time attendees to the conference to be part of our
EULAR/EMEUNET ambassador programme and receive congress mentorship from EULAR
veterans on how to make the most of your time. The details are as follows:
The EMEUNET Ambassator meeting will take place on June 8th at 12:00 pm in Room S11
o Applicants will be selected on a first-come, first-served basis
o Participants will be allocated to small groups, each with a EULAR ambassador from EMEUNET.
Your ambassador will get in contact with you prior to the meeting
o You will be invited to the welcome meeting on the first day of the congress, so that you can meet
other fellow first time attendees and your ambassadors too in an informal setting
o Participants will learn how to master the clinical and scientific EULAR programme
o Participants will be offered the chance to participate in the EMEUNET social activities
o The mentoring process will be very informal
o The programme is for free for EMEUNET members and non-members
YOUR OPINION IS
IMPORTANT!
If you are one of the participants
to the programme give us your
feedback after the event and it
will be included in next
Newsletter issue!
MAY-JUNE16
Hilfslinien anzeigen über Menu:
Ursprungsform
im Menü über:
Start | Absatz | Listenebene
EDUCATIONAL ACTIVITIES
PAGE 23
THE 3RD COUNTRY LIAISONS MEETING AT EULAR 2016
The Country Liaisons are the ambassadors of EMEUNET in the EULAR countries. They are the
ones in charge of advertising and expanding the EMEUNET Network at a national level. Through
them, the educational and career development opportunities offered by EMEUNET/EULAR find
their way to the young Rheumatology fellows/researchers, both members and non- members of
EMEUNET alike.
In the Country Liaison Subgroup, division of the EMEUNET Working Group, we work together with
the 45 current EMEUNET Country Liaisons. Last year, we organized the first Country Liaison
Meeting during the EULAR Congress in Paris. This was a first opportunity to meet in person many
of the Country Liaisons and to discuss about their experiences in promoting EMEUNET. It was a
lively and productive talk, during which various points were raised and exciting ideas were shared,
which we did our best to develop during the past year.
After the success of the first meeting, the second Country Liaison Meeting is going to take place
during the upcoming EULAR Congress in Rome. On Thursday, June 9th, from 5 to 6 PM, we
invite once again the EMEUNET Country Liaisons to group together! We will review the
highlights of the past year and invited Country Liaisons will share their experience in promoting
EMEUNET in their home countries. We count on your participation for an exciting discussion and
feedback!
EMEUNET Country Liaisons everywhere, book the date: Thursday, June 9th, from 5 to 6 PM,
Room S14, EULAR Congress Venue-Excel Exhibition Center, London
See you in London!
Your EMEUNET Country Liaison Subgroup
YOUR OPINION IS
IMPORTANT!
If you are one of the CLs that
will participate to the meeting
give us your feedback after
the event and it will be included
in next Newsletter issue!
MAY-JUNE16
2nd Country liaisons meeting
at EULAR 2015
Hilfslinien anzeigen über Menu:
Ursprungsform
im Menü über:
Start | Absatz | Listenebene
UPCOMING EDUCATIONAL EVENTS AT A GLANCE
PAGE 24
JUNE 2016
JULY 2016
EDUCATIONAL EVENTS
JUNE-JULY 2016
17° EFORT Annual Congress
o When and Where: 1-3 June, Geneva, Switzerland
o Website: https://www.efort.org/17th-efort-congress-2016-geneva-ch-1-3-june
23rd EULAR Ultrasound Course
o When and Where: 5-7 June, London, United Kingdom
o Website: http://www.eular.org/edu_course_ultrasound.cfm
5th EULAR Course for Ultrasound Trainers in Rheumatology
o When and Where: 5-7 June, London, United Kingdom
o Website: http://www.eular.org/edu_cours e_ultrasound.cfm
EULAR Congress
o When and Where: 8-11 June, London, United Kingdom
o Website: http://www.congress.eular.org/
ESSR 2016 Meeting
o When and Where: 9-11 June, Zürich, Switzerland
o Website: http://www.essr.org/cms/website.php?id=/en/index/congress_2016.htm
FOCIS 2016
o When and Where: 22-25 June, Boston, MA
o Website: http://www.focisnet.org/2013-03-07-14-01-50/2015-annual-meeting
13th International Conference on Innate Immunity
o When and Where: 23-28 June, Rhodes, Greece
o Website: http://www.aegeanconferences.org/src/App/conferences/view/104
Bone Research Society Annual Meeting 2016
o When and Where: 29 June-1 July , Liverpool, United Kingdom
o Website: http://boneresearchsociety.org/meetings/#7
Advanced Musculoskeletal Epidemiology Summer School
o When and Where: 4-8 July , Manchester, United Kingdom
o Website: http://tinyurl.com/ameSummerSchool
MAY-JUNE16
Hilfslinien anzeigen über Menu:
Ursprungsform
im Menü über:
Start | Absatz | Listenebene
MORE ON EDUCATION
PAGE 25
THE EULAR ON-LINE COURSES
All EULAR courses, as electronic ways of continuous medical education in rheumatology, are
managed by a scientific course committee responsible for the structure and content of the courses
and for ensuring regular quality control and advancement. Teams of expert authors are regularly
reviewing and updating the courses to keep up with the newest developments in the field.
REGISTRATION IS NOW OPEN
Course Duration Link to course content
11th EULAR On-line Course on
Rheumatic Diseases 2 years
http://www.eular.org/myUploadData/files/Online_full
_module_planner.pdf
8th EULAR On-line Course on
Connective Tissue Diseases (CTD) 9 months
http://www.eular.org/myUploadData/files/CTD%20w
eb%20overview%20modules_2012%20(2).pdf
6th EULAR On-line Course on Systemic
Sclerosis (SSc) 9 months
http://www.eular.org/myUploadData/files/SSc%20w
eb%20overview%20modules_2012.pdf
5th EULAR On-line Introductory
Ultrasound Course 7 months
http://www.eular.org/myUploadData/files/MSUS%2
0Module%20Planner.pdf
3rd EULAR / PReS On-line Course in
Paediatric Rheumatology9 months
http://www.eular.org/edu_online_course_paediatric.
cfm
2nd EULAR On-line Course for Health
Professionals 9 months
http://www.eular.org/myUploadData/files/HP%20we
b%20overview%20modules_2015.pdf
The EULAR On-line Courses on Rheumatic Diseases,
CTDs, SSc and US are also available as APP
THE OPINION OF TWO PARTICIPANTS:
“Ultrasonography is essential for the training of Rheumatologists and represents a key aspect of patient’s evaluation. The
EULAR On-line Introductory Ultrasound Course offers theoretical basic skills on musculoskeletal ultrasound in rheumatic
diseases as well as in healthy subjects. The high quality of contents as well as the experience of the Faculty are the two
main reasons to join this course. Moreover, the website is straightforward and very easy to use. Upon passing the final
examination, EULAR releases a certificate. This course is very useful for Rheumatologists who would like to acquire a
basic theoretical knowledge on musculoskeletal ultrasound.”
“I attended the EULAR On-line Introductory Ultrasound Course. It is a well structured basic course on ultrasonography that
is divided in different modules according to the different anatomical sites. Each module includes specific exercises and the
final test. I found this course very interesting and it provided me with a complete overview of ultrasonography in
rheumatology. I would recommend this course as to me it was overall more useful and formative compared to some
different on-site courses I previously attended.”
MAY-JUNE16
Hilfslinien anzeigen über Menu:
Ursprungsform
im Menü über:
Start | Absatz | Listenebene
MORE ON EDUCATION
PAGE 26
The aim of this intensive and interactive EULAR CAP course is to provide all participantswith an update on the power of the safe and non-invasive nailfoldvideocapillaroscopy (NVC) technique in the field of rheumatic diseases, in particularfor the early diagnosis of the scleroderma spectrum diseases, its predictability andprognostic value, as well as its role as a tool for the therapeutic follow up.
Participants will be fully involved in interactive theoretical and practical capillaroscopicsessions (Learning and Testing sessions) engaging a large number of rheumaticpatients. Updated clinical sessions concerning the diagnostic/prognostic value of NVC indiseases such as systemic sclerosis and the effects of targeted therapies onmicrocirculation and immune-inflammatory reaction will represent a stimulating gym basedon large clinical cases discussion. Links between the CAP patterns and biomarkers suchas autoantibodies will also be updated since evoluted.In particular, reading and scoring (manual and automated systems) of thevideocapillaroscopic images of living patients will be discussed and their predictive value toidentify possible clinical complications (i.e. digital ulcers in systemic sclerosis, lunginvolvement etc.) will be analyzed including in the pediatric population. Recent internationalstudies reported (CAP study) about new predictive models or index based oncapillaroscopic analysis. New sessions on practical evaluation of the peripheral bloodflow by laser doppler and LASCA imaging have been introduced. Lessons andpractical session on skin ultrasound (US) evaluation will be also available and will becombined with the severity of the videocapillaroscopic images (patterns) in living patients.Important links between CAP, laser blood flow analysis and clinical results of therapies, willbe presented and discussed for the follow up of patients.At the end of this top course that is supported by a tutorial team formed by some of thebest worlds experts on the matter, the participants will be able to use the capillaroscopy fortheir day-to-day staging and follow-up in particular of patients affected by sclerodermaspectrum diseases.
Next EULAR Course on Capillaroscopy will take place on 8-10 September 2016 in Genova, Italy
REGISTER NOW TO SAVE YOUR PLACE!TRAVEL BURSARIES ALSO AVAILABLE
For information and to register visit: http://www.eular.org/edu_course_capillaroscopy.cfm
THE EULAR COURSE ON CAPILLAROSCOPY
MAY-JUNE16
Hilfslinien anzeigen über Menu:
Ursprungsform
im Menü über:
Start | Absatz | Listenebene
MORE ON EDUCATION
PAGE 27
THE EULAR POSTGRADUATE COURSE
With its postgraduate course, EULAR seeks to update the professional knowledge of young
rheumatologists from around the world, whilst giving the participants the opportunity to meet and
exchange ideas and experiences. Target participants are fellows/residents in rheumatology,
clinician scientists in rheumatology, newly certified rheumatologists as well as more experienced
rheumatologists who need to remain up-to-date in rheumatology and immunology. A unique 3 day
refresher, "crash course", in clinical and experimental rheumatology taught by selected faculty of
European experts in a very interactive and cordial environment. Participants have the opportunity
to meet the experts in an informal setting and network with trainees and rheumatologists from all
over the world. The course includes interactive workshop sessions and participants choose which
to attend (How to design a clinical trial in rheumatic diseases, how to study adverse events of new
therapies, how to design a study to understand risk factors, how to design a study to define critical
molecular pathways in a rheumatic disease, how to review an abstract, how to write a paper).
Next EULAR Postgraduate Course will take place on23-26 october 2016 in Prague, Czech Republic
REGISTRATION OPENS IN MAY, TRAVEL BURSARIES ALSO AVAILABLE
For more information and to register: http://www.eular.org/edu_course_postgraduate.cfm
THE OPINION OF A PARTICIPANT:
Is it possible to learn the many facets of rheumatology within three days, discuss the arthritides, vasculitides and
connective tissue diseases, and make new friends from all over the world? No, of course, that’s not very realistic, but
the EULAR Postgraduate Course comes very close to fulfilling these challenges. The three day course is designated
to clinical residents and fellows who already have solid knowledge and basic skills in rheumatology. Based on that,
the participants acquire general scientific and in-depth clinical knowledge about the major rheumatic diseases. The
programme covers a great deal of what clinicians really need to know in their clinical routine, presented and
discussed by world-leading experts of the field of rheumatology. With participants from Europe, Africa, and the Near
East, the EULAR Postgraduate Course is international and exciting. It’s amazing to learn that the standard of care in
rheumatology is high worldwide, and fascinating to discover the subtle differences in how clinical practice looks like in
various countries. Despite a very dense and compacted schedule, the course offers enough leaves to exchange one’s
experiences with international fellow students from all over the world. One central element of the EULAR
Postgraduate Course is the vivid interaction between teachers and students. The organisers foster these interactions
by organising case discussions and workshops in small groups. During the coffee breaks, at lunch and dinner the
teachers mix with the students, so that it is always easy to have in-depth discussions, make new friends and build
networks. The organisers and teachers created a safe and pleasant learning atmosphere. Ingrid Lundberg, head of
the organising committee and moderator of the course, actively involved the students and guided the discussions
upon the need of the participants. In addition to Ingrid’s dedication, the perfect organisational work by Gabriela Kluge
from the EULAR Secretariat and the MCI group merit special thanks: They brought together the international group of
teachers and students in Prague, one of Europe’s historical centers of science and education.
Christian Beyer, EMEUNET Working Group member, Germany
MAY-JUNE16
Hilfslinien anzeigen über Menu:
Ursprungsform
im Menü über:
Start | Absatz | Listenebene
MORE ON EDUCATION
PAGE 28
THE EMEUNET CALENDAR
We have recently set up a new calendar of events and deadlines that can be found on the
EMEUNET website http://emeunet.eular.org/calendar.cfm
This calendar offers the great opportunity to be synchronized with your own agenda, so that you
will never miss a deadline!
You can use applications such as outlook, using the following ICAL links:
For deadlines: ICS file deadlines
For events: ICS file events
Following the links, you will download a .ics file, if you have outlook installed the calendar should
be automatically added to your agenda when opening the file.
If you have an android phone, the calendar will be automatically available on your phone.
If you have an iPhone, you can easily set it to automatically synchronize with a google account, by
following the instructions at this link
http://www.digitaltrends.com/mobile/sync-multiple-google-calendars-on-iphone-or-ipad
We hope you will find this service useful and we welcome your feedback, should anything go
wrong with the synchronization or should you have any suggestions.
Your EMEUNET Education and Social Media Subgroups
MAY-JUNE16
Young investigators of EMEUNET are from now on an integral part of all task forces and
committees working on new EULAR recommendations. This is a wonderful chance for
EMEUNET to increase its visibility and for you to accelerate your academic career.
Last call came from the EULAR study group for the new EULAR recommendations for the
management of foot and ankle conditions in people with rheumatoid arthritis.
Take a look at emails from EMEUNET and find the opportunity most suitable for you!
JOIN THE TASK FORCES AND COMMITTEES
Hilfslinien anzeigen über Menu:
Ursprungsform
im Menü über:
Start | Absatz | Listenebene
MORE ON EDUCATION
PAGE 29
SESSION PROPOSALS FOR EULAR 2017
EMEUNET Working Group members have the chance to submit their ideas for the Young
Rheumatologist Sessions at EULAR 2017.
Session proposals will be discussed within EULAR scientific committee and if your session
proposal is accepted, you will also be suggested as the session Chair at EULAR. This could be an
exciting opportunity to chair a session! Last year, eight proposals were accepted. You will have the
chance to enjoy these sessions in London.
If you would like to join the EMEUNET WG and be actively involved in such activities keep an eye
on emails from EMEUNET and do not miss next Call for application!
MAY-JUNE16
More information about EMEUNET can be found
in http://emeunet.eular.org
You can also reach us through the following
email [email protected]
www.facebook.com/EMEUNET
www.twitter.com/EMEUNET